← Back to Search

Psychotherapy for PTSD Due to Military Sexual Trauma

N/A

Recruiting

Led By JoAnn Difede, PhD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments

Be older than 18 years old

Must not have

Lifetime or current diagnosis of schizophrenia or other psychotic disorder, bipolar disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 15 weeks in the ipt condition, 11 weeks in the et condition

Awards & highlights

No Placebo-Only Group

Summary

This trial is comparing two types of therapy to see which is more effective in treating PTSD due to Military Sexual Trauma.

Who is the study for?

This trial is for male and female military personnel who have PTSD due to Military Sexual Trauma (MST). Participants must speak English, be able to consent, have been stable on psychotropic medication for 60 days, and score over 40 on the CAPS assessment. They should not have unstable medical conditions or substance dependence in the last 90 days.

What is being tested?

The study compares Exposure Therapy (ET) with Interpersonal Psychotherapy (IPT) to treat PTSD from MST. It aims to determine if both therapies are equally effective, potentially broadening treatment options for those affected by MST.

What are the potential side effects?

While specific side effects are not listed for these therapies, common reactions can include temporary increases in distress, emotional discomfort during sessions, and potential strain in personal relationships outside of therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can understand and agree to the study's requirements.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with schizophrenia, bipolar disorder, or another psychotic disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 15 weeks in the ipt condition, 11 weeks in the et condition

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 15 weeks in the ipt condition, 11 weeks in the et condition

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 15 weeks in the ipt condition, 11 weeks in the et condition for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in CAPS-5 scores from baseline to post-treatment for the ET treatment group

Change in CAPS-5 scores from baseline to post-treatment for the IPT treatment group

Difference in mean Clinician Administered PTSD Scale-5 (CAPS-5) score changes between the Exposure Therapy (ET) and Interpersonal Psychotherapy (IPT) treatment groups from baseline to post-treatment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Interpersonal PsychotherapyActive Control1 Intervention

Participants receive 14 weekly 50-minute Interpersonal Psychotherapy sessions focused on the interpersonal sequelae of trauma in current daily life.

Group II: Exposure TherapyActive Control1 Intervention

Participants receive 10 90-minute exposure therapy sessions for PTSD following the treatment procedures as outlined in the standard Prolonged Exposure therapy manual.

0 / 2Eligibility criteria met